Benson J Edagwa

11PUBLICATIONS
28CO-AUTHORS
Haematological tumoursMedical devicesGene and molecular therapyMedical molecular engineering of nucleic acids and proteinsPowder and particle technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 27, 2026
Combinatorial Therapy with Long-Acting Tenofovir and Tizoxanide Controls Viral Replication and Liver Inflammation in a Murine AAV-HBV Model of Chronic Hepatitis B.

|Jan 21, 2026
An ultra-long-acting dimeric bictegravir prodrug defined by a short pharmacokinetic tail.

Mohammad Ullah Nayan, Brady Sillman, Srijanee Das

|Aug 01, 2025
A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression.

Samiksha S Raut, Srijanee Das, Grace Bybee

|Mar 04, 2025
An Ultra-Long-Acting Dimeric Bictegravir Prodrug Defined by a Short Pharmacokinetic Tail.

Benson Edagwa, Mohammad Ullah Nayan, Brady Sillman

|Dec 23, 2022
An ultralong-acting tenofovir ProTide nanoformulation achieves monthslong HBV suppression.

Srijanee Das, Weimin Wang, Murali Ganesan

|Jun 10, 2022
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

Suyash Deodhar, Brady Sillman, Aditya N Bade

Pageof 2

Frequent Collaborators

11 joint publications

Howard Gendelman

6 joint publications

Samuel M Cohen

4 joint publications

Brady Sillman

4 joint publications

Srijanee Das